4//SEC Filing
Mehalick David 4
Accession 0001683168-24-000159
CIK 0001759186other
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 5:30 PM ET
Size
8.0 KB
Accession
0001683168-24-000159
Insider Transaction Report
Form 4
Mehalick David
DirectorCEO and President10% Owner
Transactions
- Purchase
Common Stock
2024-01-05$0.69/sh+5,050$3,484→ 2,762,611 total - Purchase
Common Stock
2024-01-08$0.67/sh+6,000$4,020→ 2,768,611 total - Purchase
Common Stock
2024-01-08$0.66/sh+14,004$9,243→ 2,782,615 total
Footnotes (1)
- [F1]Includes 156,250 shares of common stock that are issuable upon exercise of options that are or will become exercisable in the next 60 days. exercise of options that are or will become exercisable in the next 60 days.
Documents
Issuer
Coeptis Therapeutics Holdings, Inc.
CIK 0001759186
Entity typeother
Related Parties
1- filerCIK 0001846623
Filing Metadata
- Form type
- 4
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 5:30 PM ET
- Size
- 8.0 KB